New obesity drug shows promise in japanese trial
NCT ID NCT06176365
First seen Nov 01, 2025
Summary
This study tested a new medicine called survodutide for weight loss in 274 Japanese adults with obesity and related health problems like diabetes or high blood pressure. Participants received weekly injections of survodutide or a placebo for about 1.5 years, along with diet and exercise advice. The main goals were to see how much weight they lost and if at least 5% of body weight was reduced.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chiba University Hospital
Chiba, Chiba, 260-8677, Japan
-
Clinical Research Hospital Tokyo
Tokyo, Shinjuku-ku, 160-0004, Japan
-
Dojinkinenkai Meiwa Hospital
Tokyo, Chiyoda-ku, 101-0041, Japan
-
Fukuwa Clinic
Tokyo, Chuo-ku, 104-0031, Japan
-
Gifu University Hospital
Gifu, Gifu, 501-1194, Japan
-
HS Clinic
Tokyo, Shinjuku-ku, 169-0072, Japan
-
Hosokawa Surgery Clinic
Aichi, Nagoya, 453-0812, Japan
-
Ijinkai Takeda General Hospital
Kyoto, Kyoto, 601-1495, Japan
-
Ikebukuro Metropolitan Clinic
Tokyo, Toshima-ku, 171-0021, Japan
-
Jiyugaoka Yamada Clinic
Hokkaido, Obihiro, 080-0848, Japan
-
Kobe University Hospital
Hyogo, Kobe, 650-0017, Japan
-
Medical Corporation KEISEIKAI Kajiyama Clinic
Kyoto, Kyoto, 600-8898, Japan
-
Morinagaueno Clinic
Kumamoto, Kumamoto, 860-0863, Japan
-
Motomachi Takatsuka Naika Clinic
Kanagawa, Yokohama, 231-0023, Japan
-
Nagoya City University Hospital
Aichi, Nagoya, 467-8602, Japan
-
New Medical Research System Clinic
Tokyo, Hachioji, 192-0046, Japan
-
OCROM Clinic
Osaka, Suita, 565-0853, Japan
-
Osaka Metropolitan University Hospital
Osaka, Osaka, 545-8586, Japan
-
Saino Clinic
Saitama, Tokorozawa, 359-1141, Japan
-
Shimamura Kinen Hospital
Tokyo, Nerima-ku, 177-0051, Japan
-
Shinei Medical Healthcare Clinic
Tokyo, Suginami-ku, 166-0003, Japan
-
Suidoubashi Medical Clinic
Tokyo, Chiyoda-ku, 101-0065, Japan
-
ToCROM Clinic
Tokyo, Shinjyuku-ku, 160-0008, Japan
-
Tokyo Asbo Clinic
Tokyo, Chuo-ku, 104-0031, Japan
-
Tokyo Center Clinic
Tokyo, Chuo-ku, 103-0028, Japan
-
Tokyo-Eki Center-building Clinic
Tokyo, Chuo-ku, 103-0027, Japan
-
Yamasaki Family Clinic
Hyogo, Amagasaki, 660-0861, Japan
-
Yoshimura Clinic
Kumamoto, Kumamoto, 861-8039, Japan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.